Navigation Links
Gene assay to help to predict lung cancer treatment resistance
Date:8/26/2009

The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involved in drug sensitivity and resistance and actual in vitro chemosensitivity.

Ian Cree, from Queen Alexandra Hospital, Portsmouth, UK, led a team of researchers who assessed the chemosensitivity of a series of 49 NSCLC tumors and compared this with quantitative expression of putative resistance genes measured by RT-PCR. He said, "There was considerable heterogeneity between tumors, and while this showed no direct correlation with individual gene expression, there was strong correlation of multi-gene signatures for many of the single chemotherapy agents and combinations tested. This may allow the definition of predictive signatures to guide individualized chemotherapy in lung cancer".

The researchers tested docetaxel, cisplatin, gemcitabine and combinations of the agents on tumour cells taken from 49 fresh NSCLC samples. There were considerable differences between tumors in their sensitivity to individual agents and combinations, though the combination of cisplatin + gemcitabine was usually the most active.

When these results were compared to the gene expression in the tumors, Cree and his colleagues were able to identify a number of patterns, especially in chemosensitivity to combinations of treatments. Cree said, "The genes identified in this study fall into several categories, linked with much studied mechanisms such as metabolism within the cell, membrane drug pumps, and DNA repair, but also with apoptosis, suggesting that the general susceptibility of the cell to undergo this process may be an important determinant of tumor chemosensitivity, outweighing more specific mechanisms".


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-319-22165
BioMed Central
Source:Eurekalert

Page: 1

Related medicine news :

1. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
4. Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays
5. Multiple Independent Studies Report on Use of Cylexs Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients
6. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
7. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
8. Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
9. Associates of Cape Cod (ACC) and MDS Analytical Technologies Collaborate to Offer a More Robust LAL Endotoxin Assay Platform
10. Battelle to Perform Verification Studies of IntelligentMDxs Proprietary Molecular Diagnostic Assay Process
11. Development of Novel Assays Vital for the European Immunoassay Diagnostics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 2015 Coffee could not only perk you ... from gum disease, researchers have found. , They found that ... Coffee contains antioxidants. Antioxidants fight gum disease. Does coffee, then, ... Boston Univ. Henry M. Goldman School of Dental Medicine explored ... issue of the Journal of Periodontology. , “This is the ...
(Date:3/28/2015)... 2015 With more than 4,500 ... of osteoporosis, osteoarthritis and musculoskeletal diseases gathered here ... be the first time in the 17-year history ... the hot-button topic is an emerging non-pharmaceutical protocol ... scientific principles of Wolff’s law, osteogenic loading at ...
(Date:3/28/2015)... FL (PRWEB) March 28, 2015 ... conditions coverage is made available to all visitors who ... effective immediately. All members are encouraged to purchase the ... to avoid lack of proper coverage for pre-existing medical ... from one or two medical conditions with serious consequences ...
(Date:3/28/2015)... One in three young athletes who ... today at the American Orthopaedic Society for Sports Medicine’s ... long term success of surgery for patients aged 18 ... from 242 patients who underwent ACL reconstruction between 1993 ... FRACS, from North Sydney Orthopaedic and Sports Medicine Centre. ...
(Date:3/28/2015)... 2015 Genomic medicine experts have sequenced ... for the first time, key information for understanding and ... the newly posted story on the Surviving Mesothelioma ... British Columbia, the British Columbia Cancer Agency, and PhenoPath ... underlying molecular alterations and mutations that can lead to ...
Breaking Medicine News(10 mins):Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2
... Israel, Oct. 15 Atlantium Technologies, an Israeli-based ... Optic Disinfection(TM) ultraviolet (UV) light water pasteurization and ... for regulatory compliance in the U.S. dairy industry. ... U.S. Food and Drug Administration finalized the 2009 ...
... 15 SmartOps Corporation , the market ... Godshall, vice president, SmartOps, and Jerry Saltzman, senior director, supply ... present during the SAP® World Tour ... Godshall will discuss how enterprise inventory optimization plays a crucial ...
... BRIDGEWATER, N.J., Oct. 15 In support of National ... new initiative to expand its commitment to raising awareness ... is sharing findings from the GRACE (Gender, Race And ... in North American women previously treated with HIV medications ...
... sees a drop in cases following free Gardasil shots, researchers ... of genital warts have declined sharply since vaccination of teen ... in Australia in 2007, a new study has found. , ... cervical cancer. , Researchers analyzed data on new clients receiving ...
... give back to the communities in the cities visited ... Society for Radiation Oncology (ASTRO) is partnering with Halos ... Halos of Hope will work with ASTRO by participating ... Meeting, scheduled for November 1-5, 2009, at McCormick Place ...
... 2009 Elsevier, a world-leading publisher of scientific, ... today the launch of a new peer-reviewed scientific ... http://www.elsevier.com/locate/sste ). The first issue was published in ... for academics and scholars in the growing fields ...
Cached Medicine News:Health News:Atlantium Technologies' UV System Provides U.S. Dairy Processors With the Equivalent to Heat-Pasteurized Water 2Health News:Atlantium Technologies' UV System Provides U.S. Dairy Processors With the Equivalent to Heat-Pasteurized Water 3Health News:SmartOps and Wyeth Consumer to Present at SAP(R) World Tour 2009 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 2Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 3Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 4Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 5Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 6Health News:Tibotec Therapeutics Recognizes National Latino AIDS Awareness Day With Information and Insights for the Latino Community 7Health News:Fewer Genital Warts Thanks to HPV Vaccine Program 2Health News:Elsevier announces launch of Spatial and Spatio-temporal Epidemiology 2
(Date:3/27/2015)... , March 27, 2015 Concord ... "Company") (NYSE: CCM ), a leading specialty ... largest network of radiotherapy and diagnostic imaging centers ... the signing of a purchase agreement under which ... owned subsidiary of the Company, agreed to acquire ...
(Date:3/26/2015)... ON , March 26, 2015 /PRNewswire/ - Pivotal Therapeutics ... pharmaceutical company with a focus on Omega-3 therapies for ... 25, 2015 it issued 763,752 common shares of the ... of interest for the period of December 5 th ... its outstanding Convertible Notes that is due on or ...
(Date:3/26/2015)... March 26, 2015  OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... clinical developments and announced fourth quarter and year ... Developments and Anticipated Near-term MilestonesCustirsen , ... to negotiate the termination of their collaboration and ... final termination agreement are ongoing. , Two ...
Breaking Medicine Technology:Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 2Concord Medical Announces Acquisition of Fortis Surgical Hospital in Singapore 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
... announced today that it has updated coverage on ... Company")and maintains its twelve month target price of $6.50. Ross ... Company, Opexa,s lead clinical candidate Tovaxin®, an autologous cellular immunotherapy ... to advance into a pivotal Phase 3 clinical study in ...
... Electronics, a San Jose, California based cable and harness assembly ... in San Jose, CA.  The company will add another 12,500 ... stay ahead of our customers, needs and these new initiatives ... that," says VP of Operations, Ruben Macias. The plant expansion ...
Cached Medicine Technology:Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50 2DC Electronics Expands Facilities to Increase Capacity 2
ArcticTemp Upright Freezer -20C. Quick, even freezing. Heavy duty compressor. Deep door racks. Front gated bottom shelf. Interior light. Locks One year warranty on unit and 5 year warranty on compres...
... F 265 is a highly accurate portable, waterproof ... temperature measurements. Temperature compensated pH results can be ... or a 3-in-1 electrode. • This GLP/GMP compliant ... a printer or a computer. Up to 100 ...
... 12 shelves. Over-sized compressor. Triple pane thermal ... Self-Contained System No plumbing required. Equipped ... Year Warranty on Parts & Labor and an ... Also available as a chromatography unit which includes ...
... 3 slide doors, 12 shelves.Over-sized compressor. ... Fluorescent interior lighting. Self-Contained System No plumbing ... Full One Year Warranty on Parts & ... Compressor. Also available as a chromatography ...
Medicine Products: